Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cannabinoid and opioid interactions: Implications for opiate dependence and withdrawal
Jillian L. Scavone, Robert C. Sterling, Elisabeth J. Van Bockstaele
Neuroscience (2013) Vol. 248, pp. 637-654
Open Access | Times Cited: 185

Showing 26-50 of 185 citing articles:

Association Between Cannabis Use and Opioid Consumption, Pain, and Respiratory Complications After Surgery: A Retrospective Cohort Analysis
Elyad Ekrami, Sinem Sarı, Orkun Kopac, et al.
Anesthesia & Analgesia (2024) Vol. 139, Iss. 4, pp. 724-733
Closed Access | Times Cited: 7
Naltrexone Maintenance Decreases Cannabis Self-Administration and Subjective Effects in Daily Cannabis Smokers
Margaret Haney, Divya Ramesh, Andrew Glass, et al.
Neuropsychopharmacology (2015) Vol. 40, Iss. 11, pp. 2489-2498
Open Access | Times Cited: 62
Impact of Efficacy at theμ-Opioid Receptor on Antinociceptive Effects of Combinations ofμ-Opioid Receptor Agonists and Cannabinoid Receptor Agonists
David R. Maguire, Charles P. France
Journal of Pharmacology and Experimental Therapeutics (2014) Vol. 351, Iss. 2, pp. 383-389
Open Access | Times Cited: 58
Novel Pharmacologic Approaches to Treating Cannabis Use Disorder
Rebecca E. Balter, Ziva D. Cooper, Margaret Haney
Current Addiction Reports (2014) Vol. 1, Iss. 2, pp. 137-143
Open Access | Times Cited: 53
Opioid withdrawal suppression efficacy of oral dronabinol in opioid dependent humans
Michelle R. Lofwall, Shanna Babalonis, Paul A. Nuzzo, et al.
Drug and Alcohol Dependence (2016) Vol. 164, pp. 143-150
Open Access | Times Cited: 51
Pregabalin for the Treatment of Drug and Alcohol Withdrawal Symptoms: A Comprehensive Review
Rainer Freynhagen, Miroslav Bačkonja, Stephan A. Schug, et al.
CNS Drugs (2016) Vol. 30, Iss. 12, pp. 1191-1200
Open Access | Times Cited: 48
The Impact of Medical Cannabis on Intermittent and Chronic Opioid Users with Back Pain: How Cannabis Diminished Prescription Opioid Usage
Kevin M. Takakuwa, Jeffrey Y. Hergenrather, Frances S. Shofer, et al.
Cannabis and Cannabinoid Research (2020) Vol. 5, Iss. 3, pp. 263-270
Open Access | Times Cited: 44
Toxicity prediction and effect characterization of 90 pharmaceuticals and illicit drugs measured in plasma of fish from a major European river (Sava, Croatia)
Olga Malev, Mario Lovrić, Draženka Stipaničev, et al.
Environmental Pollution (2020) Vol. 266, pp. 115162-115162
Closed Access | Times Cited: 40
Endocannabinoid Signaling in Motivation, Reward, and Addiction
Claudia Sagheddu, Anna Lisa Muntoni, Marco Pistis, et al.
International review of neurobiology (2015), pp. 257-302
Closed Access | Times Cited: 44
The dynamic interaction between pain and opioid misuse
Adrianne R. Wilson‐Poe, José A. Morón
British Journal of Pharmacology (2017) Vol. 175, Iss. 14, pp. 2770-2777
Open Access | Times Cited: 43
Prospects for the Use of Cannabinoids in Psychiatric Disorders
Michał Graczyk, Małgorzata Łukowicz, Tomasz Dzierżanowski
Frontiers in Psychiatry (2021) Vol. 12
Open Access | Times Cited: 28
“I got a bunch of weed to help me through the withdrawals”: Naturalistic cannabis use reported in online opioid and opioid recovery community discussion forums
Meredith C. Meacham, Alicia L. Nobles, D. Andrew Tompkins, et al.
PLoS ONE (2022) Vol. 17, Iss. 2, pp. e0263583-e0263583
Open Access | Times Cited: 22
Cannabinoids and drug metabolizing enzymes: potential for drug-drug interactions and implications for drug safety and efficacy
Keti Bardhi, Shelby Coates, Christy J. W. Watson, et al.
Expert Review of Clinical Pharmacology (2022) Vol. 15, Iss. 12, pp. 1443-1460
Open Access | Times Cited: 21
Involvement of CB1R and CB2R Ligands in Sleep Disorders and Addictive Behaviors in the Last 25 Years
Marcel Pérez-Morales, Rodolfo Espinoza-Abad, Fabio Garcı́a-Garcı́a
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 266-266
Open Access
Medicine vs. Myth: Exploring the Therapeutic Potential of Cannabis for Opioid Use Disorder and Pain
Pooja R. Sarkar, Charlene D. Vincent, Anthony Szeto, et al.
Current Addiction Reports (2025) Vol. 12, Iss. 1
Closed Access
Safety of oral dronabinol during opioid withdrawal in humans
Crystal Jicha, Michelle R. Lofwall, Paul A. Nuzzo, et al.
Drug and Alcohol Dependence (2015) Vol. 157, pp. 179-183
Open Access | Times Cited: 40
Differential effects of endocannabinoid catabolic inhibitors on morphine withdrawal in mice
Thomas F. Gamage, Bogna M. Ignatowska‐Jankowska, Pretal P. Muldoon, et al.
Drug and Alcohol Dependence (2014) Vol. 146, pp. 7-16
Open Access | Times Cited: 37
Novel associations between FAAH genetic variants and postoperative central opioid-related adverse effects
Senthilkumar Sadhasivam, X Zhang, Vidya Chidambaran, et al.
The Pharmacogenomics Journal (2015) Vol. 15, Iss. 5, pp. 436-442
Open Access | Times Cited: 37
Exploring the first Rimonabant analog-opioid peptide hybrid compound, as bivalent ligand for CB1 and opioid receptors
Adriano Mollica, Sveva Pelliccia, Valeria Famiglini, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2017) Vol. 32, Iss. 1, pp. 444-451
Open Access | Times Cited: 36
No evidence for reduction of opioid-withdrawal symptoms by cannabis smoking during a methadone dose taper
David H. Epstein, Kenzie L. Preston
American Journal on Addictions (2015) Vol. 24, Iss. 4, pp. 323-328
Open Access | Times Cited: 34
Preclinical Studies of Cannabinoid Reward, Treatments for Cannabis Use Disorder, and Addiction-Related Effects of Cannabinoid Exposure
Leigh V. Panlilio, Zuzana Justinová
Neuropsychopharmacology (2017) Vol. 43, Iss. 1, pp. 116-141
Open Access | Times Cited: 34
Cannabis use during methadone maintenance treatment for opioid use disorder: a systematic review and meta-analysis
Heather McBrien, Candice Luo, Nitika Sanger, et al.
CMAJ Open (2019) Vol. 7, Iss. 4, pp. E665-E673
Open Access | Times Cited: 30
Possible therapeutic applications of cannabis in the neuropsychopharmacology field
Javier Fernández‐Ruíz, Ismael Galve‐Roperh, Onintza Sagredo, et al.
European Neuropsychopharmacology (2020) Vol. 36, pp. 217-234
Closed Access | Times Cited: 30
The Efficacy of Medical Marijuana in the Treatment of Cancer-Related Pain
Ian Pawasarat, Emily M. Schultz, Justin C. Frisby, et al.
Journal of Palliative Medicine (2020) Vol. 23, Iss. 6, pp. 809-816
Closed Access | Times Cited: 28
Changes in substance use in relation to opioid agonist therapy among people who use drugs in a Canadian setting
Huiru Dong, Kanna Hayashi, M‐J Milloy, et al.
Drug and Alcohol Dependence (2020) Vol. 212, pp. 108005-108005
Open Access | Times Cited: 28

Scroll to top